Pasithea Therapeutics announces annual shareholder meeting

Investors will vote on a reverse stock split amendment allowing a 1-for-2 to 1-for-20 consolidation, with the final ratio set by the board.

Stockholders will vote on the election of two Class III directors, including Tiago Reis Marques and Lawrence Steinman.

The meeting will also seek ratification of CBIZ CPAs as independent registered public accounting firm for fiscal 2026.

Pasithea Therapeutics will hold its annual stockholder meeting virtually on Sept. 9, 2026.